GoStudent Raises €70M in Series B Funding
GoStudent, a Vienna, Austria-based edtech company, raised €70M in Series B funding.
GoStudent, a Vienna, Austria-based edtech company, raised €70M in Series B funding.
Storyblok, a Linz, Austria-founded headless CMS for developers and marketers to deliver content experiences on any digital platform, raised an $8.5m Series A funding.
European footprint and automotive inbound logistics capabilities expanded with deal IRVING, Texas–(BUSINESS WIRE)–Neovia Logistics, a global supplier of logistics services, announced today the company has closed its acquisition of Temmel Logisitk Center (TLC), an Austria-based provider of automotive inbound logistics support services. The companies announced plans for the deal in a press release on December […]
GoStudent, a Vienna, Austria-based online tutoring company, raised an additional €5m in Series A extension funding.
Speedinvest, a pan-European early-stage venture capital firm, launched its second specialist Networks Effects fund with €33M.
Bitpanda, a Vienna, Austria-based crypto exchange company, closed a $52m Series A funding round.
F2G, a UK- and Austria-based biotech developing novel therapies for life-threatening systemic fungal infections, secured US $60.8m in new financing.
kompany, a Vienna, Austria-based RegTech platform for Business KYC (KYB), raised newly €6m in funding.
Apex Ventures, a Vienna, Austria-based venture capital firm, is launching its second fund, which will focus on digital health startups.
byrd, a Berlin, Germany and Vienna, Austria-based e-commerce fulfillment platform that allows merchants to access warehouses internationally and ship globally, raised €5m in Series A funding.
SignD Identity, a Vienna, Austria-based specialist in digital onboarding and KYC, raised €1m in funding.
GoStudent, a Vienna, Austria-based e-learning startup, closed an €8.3M Series A funding round.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, completed the acquisition of Themis, a company focused on vaccines and immune-modulation therapies for infectious diseases and cancer.
Merck (NYSE: MRK), through a subsidiary, is to acquire Themis, a Vienna, Austria-based company focused on vaccines and immune-modulation therapies for infectious diseases and cancer.
Adverity, a Vienna, Austria-based data analytics company targeting applications in media, marketing, and ecommerce areas, raised $30m in Series C financing.